Drug news
Baxter launches Hemopatch in EU for Haemostasis
Baxter International Inc. announced the launch of Hemopatch Sealing Hemostat, a novel collagen-based hemostatic device, following CE mark approval in Europe. Hemopatch is a resorbable hemostatic device used for surgical procedures when control of bleeding by pressure, ligature or conventional procedures is either ineffective or impractical.